← Back to Clinical Trials
Recruiting NCT06888466

NCT06888466 Personalised HeartCare: Poligenic Risk Scores Disclosure for Cardiovascular Prevention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06888466
Status Recruiting
Phase
Sponsor Catholic University of the Sacred Heart
Condition Cardiovascular Diseases
Study Type INTERVENTIONAL
Enrollment 650 participants
Start Date 2025-06-01
Primary Completion 2026-03

Trial Parameters

Condition Cardiovascular Diseases
Sponsor Catholic University of the Sacred Heart
Study Type INTERVENTIONAL
Phase N/A
Enrollment 650
Sex ALL
Min Age 40 Years
Max Age N/A
Start Date 2025-06-01
Completion 2026-03
Interventions
The result of the Polygenic Risk Score will be communicated to the patient with the aim of encouraging a change in behavior

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to evaluate whether the disclosure of Polygenic Risk Scores (PRS) combined with personalized coaching on risk factors can lead to significant improvements in lifestyle behaviors among staff members at Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The study includes staff members from Fondazione Policlinico Universitario Agostino Gemelli IRCCS, enrolled at the outpatient clinics of the Cardiology Department. Main Research Questions: 1. Does receiving PRS disclosure and personalized coaching lead to significant improvements in lifestyle behaviors compared to baseline measurements? 2. How do different levels of genetic predisposition to cardiovascular diseases (CVD) impact behavioral changes following intervention? This is a single arm, pre-post clinical trial. Participant will: * Undergo genetic testing to assess their Polygenic Risk Score for CVDs * receive personalized, in-person consultation with a medical cardiologis, together with and individualized recommendations for CVD prevention based on PRS results and traditional risk factors.

Eligibility Criteria

Inclusion criteria * Traditional cardiovascular risk: The risk will be assessed using SCORE 2 (low risk \< 2.5%, moderate risk between 2.5% and 5%, high risk between 5% and 10%) or SCORE 2-OP (moderate risk \< 7.5%, high risk between 7.5% and 15%). * Blood tests: Participants must have had blood tests performed within the past 6 months. * Age: Participants must be at least 40 years old. Exclusion Criteria * Very high cardiovascular risk, as measured by SCORE 2 (very high risk \> 10%) or SCORE 2-OP (very high risk \> 15%). * Diabetes. * Familial hypercholesterolemia. * Previous cardiovascular events or established CVD

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology